Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis
about
Biomarkers of genome instability and cancer epigenetics.Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphomaAltered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysisClinical value of octamer-binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: A systematic review and meta-analysis.Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation.Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297.Long non-coding RNAs: emerging players in osteosarcoma.Characters, functions and clinical perspectives of long non-coding RNAs.CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression.The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis.Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma.Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cellsSeven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinomaUpregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications.Role of Non-Coding RNAs in the Etiology of Bladder Cancer.Comprehensive Profiling of lincRNAs in Lung Adenocarcinoma of Never Smokers Reveals Their Roles in Cancer Development and Prognosis.Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma.Therapeutic targeting of non-coding RNAs in cancer.Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis.Identification of a progression-associated long non-coding RNA signature for predicting the prognosis of lung squamous cell carcinoma.Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.MALAT1 affects ovarian cancer cell behavior and patient survival.Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage.Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Renal Cell Carcinoma Progression via Sponging miRNA-429.Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesisA seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancerPrognostic value of lncRNA ROR expression in various cancers: a meta-analysis
P2860
Q30248745-6DC0BD73-DBCB-4AA4-BEEB-333171C3FF33Q33761730-6E41D0E5-0631-441B-BE35-796AA038C766Q33798800-796E3092-236C-49E7-AE75-D8B6EB01A9BAQ36315148-9D19C9A1-56B8-4165-876E-595362A3FABDQ37709500-6487F827-ED67-4412-9565-C816876AD10FQ37740977-E813C86F-3C4E-46ED-9BDC-9DD98045D5EDQ38683315-30DD26DB-B735-48D7-BBCA-11AC7C486E23Q38737055-6FB5A309-0F75-4A34-A314-65C42B81AF32Q38822607-BD80556A-9086-44FF-BDA8-72C806E6DCE7Q39368869-93065EB7-5035-46C8-A54D-41E40FF562F1Q40350434-60CAAFEA-7DBF-4F39-85C9-72E96ACFC704Q41210332-CA7A9315-DBE1-406D-A402-F1E4A53C7A79Q41626063-9F9B5AB8-D639-436E-960E-F9C35B3972B7Q41708752-1C555510-6CF3-40DF-B174-477CD2433826Q41823084-2D924347-9801-47D2-9479-3C84C51E1575Q42838399-AC8627E8-6799-4A45-B7C1-BAEED0C6F66EQ46077218-C59B8FF3-5EB3-4551-8EF8-8BEA4A809F1BQ46236214-E337F008-65CC-46A7-8F12-3FC268F55BF5Q47119804-10702660-FCD3-47BE-A712-7D01CE73590FQ47144679-753ED3D1-E9A6-4FAC-B98E-1D6E506D16ABQ47292099-FB55BC5D-AD91-468A-8BE5-61A0564A81F0Q47935571-B7B4D52A-BD99-4571-8888-FF6E00CDD852Q48146012-A62E949F-CAD1-4A1D-A265-57FC0ECCFF06Q49591680-678BFC76-E90F-45AC-BF7B-545544AD0E30Q52903430-9E44EBAA-7195-4541-81A7-80CCD6B3F823Q53402391-572E3911-2C77-4221-8583-844AA18B2BB3Q54976725-D0622B7A-FC58-4EFD-82B7-8AF5591F46FCQ55089681-D3D27415-054C-48A5-823F-994C297A4EC5Q55121977-F4793467-E086-452E-89AD-3ECC5BD8CFCBQ57801264-5D64BD7B-2D8D-44E7-9BF8-D4F318D221AEQ58749147-C22B7085-86B3-4A25-B8A3-9BF20404D3D1Q59126023-3A5DEAD3-9D36-4FCE-9941-53E1134A7101
P2860
Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@ast
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@en
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@nl
type
label
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@ast
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@en
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@nl
prefLabel
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@ast
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@en
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@nl
P2860
P31
P1433
P1476
Clinical value of lncRNA MALAT ...... matic review and meta-analysis
@en
P2093
Guoxiong Xu
Xiaoling Tian
P2860
P304
P356
10.1136/BMJOPEN-2015-008653
P407
P5008
P577
2015-09-30T00:00:00Z